Immune suppressive activity of myeloid-derived suppressor cells in cancer requires inactivation of the type I interferon pathway.
Alicea-Torres K, Sanseviero E, Gui J, Chen J, Veglia F, Yu Q, Donthireddy L, Kossenkov A, Lin C, Fu S, Mulligan C, Nam B, Masters G, Denstman F, Bennett J, Hockstein N, Rynda-Apple A, Nefedova Y, Fuchs SY, Gabrilovich DI.
Alicea-Torres K, et al.
Nat Commun. 2021 Mar 19;12(1):1717. doi: 10.1038/s41467-021-22033-2.
Nat Commun. 2021.
PMID: 33741967
Free PMC article.